Q2 2026 – PROTAC MetID focus
April 28, 2026 4:22 pm Leave your thoughtsQ2 2026 newsletter – PROTAC MetID focus From tackling the metabolism of PROTACs to synthesising oxidised metabolites, our latest newsletter...
View Article
Q2 2026 newsletter – PROTAC MetID focus From tackling the metabolism of PROTACs to synthesising oxidised metabolites, our latest newsletter...
View Article
Welcome to Iain Beattie We’re delighted to welcome Iain Beattie to Hypha as Scientific Fellow in Biotransformation and MetID. Iain...
View Article
Paper Pick UDP-Glucuronosyl transferase mediated drug-drug interactions: An Industry perspective on recommended in vitro studies Glucuronidated metabolites have long been...
View Article
Paper Pick – Strategic Use of Benzylic Alcohols Reveals Cryptic Hydrogen-Bonding Interactions: Discovery of HBC-12551 as a Potent Non-Covalent Bruton’s...
View Article
Q1 2026 Newsletter – LC/MS-MS MetID Service Hypha provides a high quality LC-MS/MS based MetID Service to complement our existing...
View Article
Paper Pick – The role of metabolites in drug-drug interactions Our last paper pick of the year is an excellent...
View Article
Metabolism of 2024 FDA Approved Small Molecules – PART 2 By Julia Shanu-Wilson As we near the end of 2025,...
View Article
Paper Pick – The application of mechanistic absorption, distribution, metabolism and excretion studies and physiologically-based pharmacokinetic modeling in the discovery...
View Article
Launch of New MetID Services Hypha Discovery is excited to announce that we have extended our metabolite identification services to...
View Article
Paper Pick – Intestinal Secretion Is a Potentially Important Clearance Mechanism for Low Metabolic Clearance Compounds In this paper, scientists...
View Article